Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Oncol. May 15, 2014; 6(5): 139-144
Published online May 15, 2014. doi: 10.4251/wjgo.v6.i5.139
Published online May 15, 2014. doi: 10.4251/wjgo.v6.i5.139
Factor | Mean SUVmax (95%CI) | Median survival in days (95%CI) |
T stage | ||
T0 or T1 (n = 15) | 3.1 (1.5, 4.7) | Not reached |
T2 (n = 49) | 8.7 (7.0, 10.4) | 1225 (742, 1708) |
T3 (n = 183) | 12.7 (11.7, 13.7) | 495 (413, 577) |
T4 (n = 24) | 14.1 (11.6, 16.7) | 390 (186, 594) |
P < 0.001 | P < 0.001 | |
N stage | ||
N0 (n = 107) | 9.1 (8.1, 10.2) | 1094 (835, 1352) |
N1 (n = 89) | 12.9 (11.4, 14.5) | 466 (371, 561) |
N2 (n = 61) | 13.4 (11.6, 15.1) | 477 (307, 646) |
N3 (n = 14) | 14.4 (8.8, 19.9) | 530 (350, 710) |
P < 0.001 | P < 0.001 | |
UICC stage | ||
Stage 0 or 1 (n = 45) | 5.6 (4.2, 7.0) | 2092 (1060, 3124) |
Stage 2 (n = 50) | 12.1 (10.6, 13.6) | 780 (195,1365) |
Stage 3 (n = 99) | 11.9 (10.7, 13.2) | 594 (473, 715) |
Stage 4 (n = 77) | 14.4 (12.6, 16.1) | 349 (280, 418) |
P < 0.001 | P < 0.001 |
- Citation: Al-Taan OS, Eltweri A, Sharpe D, Rodgers PM, Ubhi SS, Bowrey DJ. Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma. World J Gastrointest Oncol 2014; 6(5): 139-144
- URL: https://www.wjgnet.com/1948-5204/full/v6/i5/139.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v6.i5.139